These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 15824177

  • 1. Genetic variants in the vitamin D receptor gene and prostate cancer risk.
    Hayes VM, Severi G, Padilla EJ, Eggleton SA, Southey MC, Sutherland RL, Hopper JL, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):997-9. PubMed ID: 15824177
    [Abstract] [Full Text] [Related]

  • 2. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
    Ma J, Stampfer MJ, Gann PH, Hough HL, Giovannucci E, Kelsey KT, Hennekens CH, Hunter DJ.
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):385-90. PubMed ID: 9610787
    [Abstract] [Full Text] [Related]

  • 3. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
    Onen IH, Ekmekci A, Eroglu M, Konac E, Yesil S, Biri H.
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
    [Abstract] [Full Text] [Related]

  • 4. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.
    Habuchi T, Suzuki T, Sasaki R, Wang L, Sato K, Satoh S, Akao T, Tsuchiya N, Shimoda N, Wada Y, Koizumi A, Chihara J, Ogawa O, Kato T.
    Cancer Res; 2000 Jan 15; 60(2):305-8. PubMed ID: 10667581
    [Abstract] [Full Text] [Related]

  • 5. Vitamin D receptor polymorphisms and lethal prostate cancer.
    Kibel AS, Isaacs SD, Isaacs WB, Bova GS.
    J Urol; 1998 Oct 15; 160(4):1405-9. PubMed ID: 9751364
    [Abstract] [Full Text] [Related]

  • 6. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.
    Chokkalingam AP, McGlynn KA, Gao YT, Pollak M, Deng J, Sesterhenn IA, Mostofi FK, Fraumeni JF, Hsing AW.
    Cancer Res; 2001 Jun 01; 61(11):4333-6. PubMed ID: 11389055
    [Abstract] [Full Text] [Related]

  • 7. Association between vitamin D receptor polymorphisms and prostate cancer risk in a Taiwanese population.
    Huang SP, Chou YH, Wayne Chang WS, Wu MT, Chen YY, Yu CC, Wu TT, Lee YH, Huang JK, Wu WJ, Huang CH.
    Cancer Lett; 2004 Apr 15; 207(1):69-77. PubMed ID: 15050735
    [Abstract] [Full Text] [Related]

  • 8. The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population.
    Medeiros R, Morais A, Vasconcelos A, Costa S, Pinto D, Oliveira J, Lopes C.
    J Hum Genet; 2002 Apr 15; 47(8):413-8. PubMed ID: 12181642
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    McKay JD, McCullough ML, Ziegler RG, Kraft P, Saltzman BS, Riboli E, Barricarte A, Berg CD, Bergland G, Bingham S, Brustad M, Bueno-de-Mesquita HB, Burdette L, Buring J, Calle EE, Chanock SJ, Clavel-Chapelon F, Cox DG, Dossus L, Feigelson HS, Haiman CA, Hankinson SE, Hoover RN, Hunter DJ, Husing A, Kaaks R, Kolonel LN, Le Marchand L, Linseisen J, McCarty CA, Overvad K, Panico S, Purdue MP, Stram DO, Stevens VL, Trichopoulos D, Willett WC, Yuenger J, Thun MJ.
    Cancer Epidemiol Biomarkers Prev; 2009 Jan 15; 18(1):297-305. PubMed ID: 19124512
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer.
    John EM, Schwartz GG, Koo J, Van Den Berg D, Ingles SA.
    Cancer Res; 2005 Jun 15; 65(12):5470-9. PubMed ID: 15958597
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vitamin D receptor gene polymorphisms and risk of prostate cancer: a meta-analysis.
    Ntais C, Polycarpou A, Ioannidis JP.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 15; 12(12):1395-402. PubMed ID: 14693728
    [Abstract] [Full Text] [Related]

  • 15. Vitamin D receptor genotypes/haplotypes and prostate cancer risk.
    Cicek MS, Liu X, Schumacher FR, Casey G, Witte JS.
    Cancer Epidemiol Biomarkers Prev; 2006 Dec 15; 15(12):2549-52. PubMed ID: 17164384
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Start codon polymorphisms in the vitamin D receptor and colorectal cancer risk.
    Park K, Woo M, Nam J, Kim JC.
    Cancer Lett; 2006 Jun 18; 237(2):199-206. PubMed ID: 16019132
    [Abstract] [Full Text] [Related]

  • 18. [Case-control study of the genes of receptors of the androgens of vitamin-D and of 5-alphareductase in a population of Afro-Caribbean population with prostate cancer].
    Veronique-Baudin J, Dieye M, Kouyoumdjian JC, Vacheron F, Draganescu C, Azaloux H.
    Prog Urol; 2006 Jun 18; 16(3):303-10. PubMed ID: 16821341
    [Abstract] [Full Text] [Related]

  • 19. Polymorphisms in the vitamin D receptor gene and risk of lung cancer.
    Dogan I, Onen HI, Yurdakul AS, Konac E, Ozturk C, Varol A, Ekmekci A.
    Med Sci Monit; 2009 Aug 18; 15(8):BR232-42. PubMed ID: 19644412
    [Abstract] [Full Text] [Related]

  • 20. Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression.
    Xu Y, Shibata A, McNeal JE, Stamey TA, Feldman D, Peehl DM.
    Cancer Epidemiol Biomarkers Prev; 2003 Jan 18; 12(1):23-7. PubMed ID: 12540499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.